TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 7 | 0 | -0 | -2 | -3 | -5 | -6 | -3 |
| S | %wins | 57 | 71 | 86 | 71 | 71 | 86 | 74 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/18 16:31 | 11/8/18 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Perlmutter Roger M | NJ | O | Exe V-P, | S.d | -16,968 | 75.27 | 0 | -225 | -61 | 142 | D | ||||||||||||||
2/6/12 17:35 | 2/2/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | EVP,Rese | S.d | -5,237 | 69.83 | 33 | -75 | -29 | 186 | D | 22 | 26 | 36 | 27 | 10 | 2 | 0 | 2 | 0 | -3 | -3 | 1 | 20 | 28 |
6/2/09 19:22 | 6/2/09 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S.d | -4,341 | 51.07 | 33 | -85 | -36 | 149 | D | -11 | 14 | -10 | 5 | 10 | 5 | -1 | 1 | 2 | 0 | 4 | 18 | 12 | 0 |
11/21/05 12:37 | 11/17/05 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S | -2,881 | 82.30 | 33 | -35 | -42 | 48 | D | 38 | 39 | 34 | 5 | 9 | 10 | 4 | 2 | 1 | -2 | -6 | -10 | -20 | -12 |
11/21/05 12:36 | 11/17/05 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S.d | -5,352 | 82.35 | 33 | -65 | -44 | 83 | D | 38 | 39 | 34 | 5 | 9 | 10 | 4 | 2 | 1 | -2 | -6 | -10 | -20 | -12 |
7/28/05 17:01 | 7/27/05 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S.m | -609 | 81.20 | 33 | -8 | -13 | 48 | D | 16 | 43 | 28 | 40 | 36 | 21 | 15 | 0 | -2 | 4 | -2 | -6 | -11 | -14 |
7/28/05 17:01 | 7/27/05 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S.d | -2,632 | 81.00 | 33 | -33 | -37 | 56 | D | 16 | 43 | 28 | 40 | 36 | 21 | 15 | 0 | -2 | 4 | -2 | -6 | -11 | -14 |
8/4/03 09:47 | 7/31/03 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Perlmutter Roger M | CA | O | Exe VP,R | S | -1,770 | 70.80 | 33 | -25 | -27 | 68 | D | 18 | 57 | 34 | 8 | 5 | -3 | -2 | -2 | 0 | -2 | -1 | -10 | -3 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |